Market Summary Follow <\/p>\n
Puma Biotechnology Inc is a A biopharmaceutical company <\/p>\n
PBYI - Market Data & News <\/p>\n
PBYI - Stock Valuation Report <\/p>\n
Puma Biotechnology Inc (PBYI) traded on unusually high volume on Feb. 21, as the stock lost 4.72% to close at $38.35. On the day, Puma Biotechnology Inc saw 1.1 million shares trade hands on 8,009 trades. Considering that the stock averages only a daily volume of 715,433 shares a day over the last month, this represents a pretty significant bump in volume over the norm. <\/p>\n
Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances. <\/p>\n
The stock has traded between $73.27 and $19.74 over the last 52-weeks, its 50-day SMA is now $34.44, and its 200-day SMA $41.65. Puma Biotechnology Inc has a P\/B ratio of 15.46. <\/p>\n
Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care. <\/p>\n
Headquartered in Los Angeles, CA, Puma Biotechnology Inc has 156 employees and is currently under the leadership of CEO Alan H. Auerbach. <\/p>\n
For a complete fundamental analysis analysis of Puma Biotechnology Inc, check out Equities.coms Stock Valuation Analysis report for PBYI. <\/p>\n
Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http:\/\/www.equitiespremium.com\/<\/a> to learn more about Guild Investments Market Commentary and Adam Sarhans Find Leading Stocks today. <\/p>\n To get more information on Puma Biotechnology Inc and to follow the companys latest updates, you can visit the companys profile page here: PBYIs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories. <\/p>\n All data provided by QuoteMedia and was accurate as of 4:30PM ET. <\/p>\n DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http:\/\/www.equities.com\/disclaimer<\/a> <\/p>\n <\/p>\n See the original post: Market Summary Follow Puma Biotechnology Inc is a A biopharmaceutical company PBYI - Market Data & News PBYI - Stock Valuation Report Puma Biotechnology Inc (PBYI) traded on unusually high volume on Feb. 21, as the stock lost 4.72% to close at $38.35 Continue reading
\nPuma Biotechnology Inc (PBYI) Moves Lower on Volume Spike for February 21 - Equities.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"